Terran Biosciences Announces Acquisition of a Portfolio of Nov...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
NEW YORK, Mar.12, 2022 /PRNewswire-AsiaNet/-- Terran Biosciences ("Terran"), a biotech platform company dedicated to the development of transformational therapeutics for neurological and psychiatric diseases, has entered into an agreement with Concert Pharmaceuticals ("Concert") to acquire a ...
Authors: LATEST ASIANET NEWS RELEASES